Interestingly, peripherally acting non-peptidergic agonists with preferential binding to GAL2R over GAL1R have been discovered and showed analgesic properties in rodent models of inflammation, neuropathic pain, acute pain, and epilepsy [55, 64, 65]. The gene discussed is GALR2; the disease is epilepsy.